We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$41.2M
Cap. Flow
+$4.34M
Cap. Flow %
0.58%
Top 10 Hldgs %
7.71%
Holding
486
New
109
Increased
122
Reduced
150
Closed
98

Top Buys

Rank Stock Value
1
BAP icon
Credicorp
BAP
+$3.22M
2
TTM
Tata Motors Limited
TTM
+$2.93M
3
ETN icon
Eaton
ETN
+$2.91M
4
S
Sprint Corporation
S
+$2.91M
5
RAX
Rackspace Hosting Inc
RAX
+$2.72M

Top Sells

Rank Stock Value
1
SWN
Southwestern Energy Company
SWN
+$4.17M
2
NVDA icon
NVIDIA
NVDA
+$4.14M
3
VA
Virgin America Inc.
VA
+$3.43M
4
UAL icon
United Airlines
UAL
+$3.32M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.28M

Sector Composition

Rank Sector Weight
1 Technology 15.46%
2 Healthcare 12.36%
3 Financials 10.67%
4 Consumer Discretionary 10.44%
5 Industrials 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBI icon
301
Designer Brands
DBI
$333M
$934K 0.12%
45,620
+1,313
+3% +$30.8K
EBS icon
302
Emergent Biosolutions
EBS
$248M
$872K 0.12%
+27,644
New +$803K
MRK icon
303
Merck
MRK
$318B
$865K 0.11%
14,520
+149
+1% +$8.71K
ADXS
304
DELISTED
Advaxis Inc
ADXS
$864K 0.11%
5,388
+65
+1% +$10.6K
ICLR icon
305
Icon
ICLR
$12.7B
$843K 0.11%
10,898
-156
-1% -$11.7K
BMCH
306
DELISTED
BMC Stock Holdings, Inc
BMCH
$823K 0.11%
+46,441
New +$905K
AZN icon
307
AstraZeneca
AZN
$250B
$806K 0.11%
12,257
-62
-0.5% -$4.05K
CELG
308
DELISTED
Celgene Corp
CELG
$796K 0.11%
6,193
-6,114
-50% -$662K
MGNX icon
309
MacroGenics
MGNX
$257M
$795K 0.11%
26,583
-900
-3% -$26.8K
IBRX icon
310
ImmunityBio
IBRX
$8.1B
$792K 0.11%
101,847
-653
-0.6% -$4.88K
KDNY
311
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$721K 0.1%
11,598
-462
-4% -$32.7K
KITE
312
DELISTED
Kite Pharma, Inc.
KITE
$721K 0.1%
12,904
-243
-2% -$13.5K
IOVA icon
313
Iovance Biotherapeutics
IOVA
$2.87B
$719K 0.1%
87,396
+1,689
+2% +$14.3K
AAPL icon
314
Apple
AAPL
$4.57T
$707K 0.09%
25,012
-61,072
-71% -$1.62M
ONC
315
BeOne Medicines Ltd
ONC
$39.4B
$701K 0.09%
22,751
– –
ATRA icon
316
Atara Biotherapeutics
ATRA
$76.1M
$700K 0.09%
1,309
-6
-0.5% -$3.26K
NVS icon
317
Novartis
NVS
$297B
$696K 0.09%
9,831
-49
-0.5% -$3.57K
CGEN icon
318
Compugen
CGEN
$228M
$647K 0.09%
102,694
+22,200
+28% +$150K
RAVN
319
DELISTED
Raven Industries Inc
RAVN
$646K 0.09%
+28,052
New +$605K
WVE icon
320
Wave Life Sciences
WVE
$1.2B
$628K 0.08%
19,342
-12,990
-40% -$307K
CLDX icon
321
Celldex Therapeutics
CLDX
$3.28B
$620K 0.08%
10,239
+196
+2% +$12.2K
VIXY icon
322
ProShares VIX Short-Term Futures ETF
VIXY
$183M
$614K 0.08%
68
+36
+113% +$382K
META icon
323
Meta Platforms (Facebook)
META
$1.51T
$613K 0.08%
3,589
-24,184
-87% -$3M
TCRT icon
324
Alaunos Therapeutics
TCRT
$4.86M
$612K 0.08%
725
-23
-3% -$18.5K
CLLS
325
Cellectis
CLLS
$285M
$608K 0.08%
25,254
– –
11 12
13
14 15

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q3 2016 Portfolio in Review

As of Q3 2016, Vident Investment Advisory held 486 positions worth $753M, up 5.8% from $712M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Vident Investment Advisory's Q3 2016 filing shows 109 new, 122 increased, 150 reduced and 98 closed positions. Its largest new stake was Credicorp: 20,406 shares worth $3.11M. The largest sale was Southwestern Energy Company, an estimated $4.17M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Vident Investment Advisory's largest Q3 2016 buy was Credicorp: 20,406 shares worth $3.11M.
  • Vident Investment Advisory added most to Sprint Corporation in Q3 2016, an estimated $2.91M increase.
  • Vident Investment Advisory's biggest Q3 2016 reduction was NVIDIA, cutting an estimated $4.14M.
  • Vident Investment Advisory fully exited Southwestern Energy Company in Q3 2016, selling an estimated $4.17M.
  • Vident Investment Advisory's ten largest holdings make up 7.7% of its $753M portfolio in Q3 2016.
  • Vident Investment Advisory opened 109 new positions and closed 98 in Q3 2016.
  • Vident Investment Advisory's portfolio value rose 5.8% quarter-over-quarter to $753M.

Based on Vident Investment Advisory's 13F filing for Q3 2016, filed 10 Nov 2016.